MedTrace Logo

Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population

NCT05260047 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 525

Last updated 2025-06-26

No results posted yet for this study

Summary

The main goal of this current study is to develop and optimize methods for increasing access to, uptake of, and engagement in MAT (Medication Assisted Treatment) among communities of color.

Conditions

  • Substance Use
  • Mental Health Issue
  • Opioid Use
  • Medication Assisted Treatment

Interventions

BEHAVIORAL

IMANI

For the intervention, the study will introduce and offer Medication Assisted Treatment. Those participants wishing to receive MAT will be randomized to one of two intervention IMANI + church-based telehealth MAT or IMANI + Traditional MAT + Referral and Linkage. Those who do not wish to partake of MAT services will remain in the IMANI alone.

BEHAVIORAL

Telehealth MAT

Describe what is the Telehealth MAT briefly

BEHAVIORAL

Traditional MAT plus Referral and Linkage

Describe what he traditional MAT plus referral and linkage briefly

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Chyrell Bellamy, Ph.D. · Yale University

  • Ayana Jordan, PhD. · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-20
Primary Completion
2026-10-01
Completion
2026-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05260047 on ClinicalTrials.gov